Bio-Path Stock Price (NASDAQ:BPTH)

Add to My Stocks
$1.02 $0.05 (4.67%) BPTH stock closing price Jan 17, 2017 (Closing)
Prev Close* : $1.07
Market Cap:
Day Low: $1.01
52 Week Low: $0.95
Open: $1.08
Volume: 211700
Day High: $1.1
52 Week High: $3.19

Latest Stock Market News

Latest Articles

Bio-Path News - From Partners

BPTH Stockcharts

View BPTH PE ratio, PS ratio stocks charts and compare with peers.
BPTH Chart
Note: Compare Bio-Path stock price history with the index and industry peers.

BPTH Industry Peers

Company Price Change (%)
Merus Labs International (MSLI)0.830.05 (5.68%)
Catalyst Pharma (CPRX)1.230.01 (0.81%)
Ariad Pharma (ARIA)23.640.05 (0.21%)
Macrogenics (MGNX)19.350.87 (4.3%)
Seattle Genetics (SGEN)57.721.4 (2.37%)
Stemline Therapeutics (STML)12.10.85 (6.56%)
Pdl Biopharma (PDLI)2.250.02 (0.88%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ImmunoGen (IMGN)2.560.13 (5.35%)
USANA Health Sciences (USNA)61.850.15 (0.24%)
Taro Pharma (TARO)104.920.07 (0.07%)
Top gainers from Medical-Drugs industry
* As of Jan 18, 2017
CompanyPriceChange (%)
Concert Pharma (CNCE)9.011.46 (13.94%)
Xencor (XNCR)23.312.85 (10.89%)
Egalet (EGLT)5.340.56 (9.49%)
Rigel Pharma (RIGL)2.340.17 (6.77%)
Zogenix (ZGNX)9.650.7 (6.76%)
La Jolla Pharma (LJPC)20.421.47 (6.72%)
Esperion Therapeutics (ESPR)11.20.8 (6.67%)
Top losers from Medical-Drugs industry
* As of Jan 18, 2017

Bio-Path Financial Statements

income statement20152014201320122011
Net Sales Or Revenues-----
Net Income-5.46M-4.51M-3.26M-2.58M-2.36M
Total Operating Expense5.48M4.53M3.26M2.57M2.36M
view Bio-Path Holdings Inc income statement
balance sheet20152014201320122011
Total Assets10.75M15.47M5.07M2.34M3.23M
Total Liabilities0.93M0.56M0.29M0.32M0.31M
Shareholders Equity9.81M14.91M4.78M2.01M2.91M
view Bio-Path Holdings Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-0.1M0.12M0.08M-0.02M0.27M
Net Cash From (Used By) Operating Activities-5M-3.81M-2.31M-1.99M-1.14M
Increase (Decrease) In Prop Plant And Equipment--0.12M---
view Bio-Path Holdings Inc cashflow statement

Bio-Path Stock Message Board

An investor needs to spend 1.02 to buy BPTH stock, as the closing Bio-Path stock price is 1.02. Bio-Path market capitalization is 102.34M and it represents the total market value of BPTH stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Bio-Path stock analysis.

The terms stocks and shares mean the same thing. For Ex: Bio-Path stock price and Bio-Path share price mean the same thing. The volume of shares traded stood at 211700 on the last trading day, as is evident from Bio-Path stock chart, and BPTH stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. One can observe stock price trends and check for volatility by checking Bio-Path stock price history.